Adjuvant hormone therapy in postmenopausal patients with locally advanced breast cancer: hope and reality
The clinical efficiency of adjuvant hormone therapy has been considered in patients with operable breast cancer in international ran- domized mulricenter studies. The use of aromatase inhibitors versus tamoxifen is shown to considerably improve relapse-free survival and to reduce the risk of distant...
Main Author: | V. I. Borisov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-07-01
|
Series: | Опухоли женской репродуктивной системы |
Subjects: | |
Online Access: | https://ojrs.abvpress.ru/ojrs/article/view/158 |
Similar Items
-
Breast ductal carcinoma in situ: a literature review of adjuvant hormonal therapy
by: Stephen Kinsey-Trotman, et al.
Published: (2016-12-01) -
Is the extension of adjuvant hormone therapy for breast cancer justified?
by: V. F. Semiglazov, et al.
Published: (2020-07-01) -
Efficacy and Safety of Initial 5 Years of Adjuvant Endocrine Therapy in Postmenopausal Hormone Receptor-Positive Breast Cancer: A Systematic Review and Network Meta-Analysis
by: Hao Liao, et al.
Published: (2022-05-01) -
Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients
by: Roberta Rosso, et al.
Published: (2023-01-01) -
Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study
by: Luca Arecco, et al.
Published: (2024-10-01)